SGLT2 inhibitor canagliflozin shown to improve kidney oxygenation in diabetes patients
Type 2 diabetes can lead to diabetic kidney disease, but a class of drugs that cause the kidneys to remove glucose through urine has been gaining attention. An Osaka Metropolitan University-led research group has investigated…
Read More...
Read More...